Eilenberg Wolf, Waduud Mohammed A, Davies Henry, Bailey Marc A, Scott D Julian A, Wolf Florian, Sotir Anna, Lakowitsch Sebastian, Kaider Alexandra, Heinze Georg, Brostjan Christine, Domenig Christoph M, Neumayer Christoph
Division of Vascular Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Front Cardiovasc Med. 2023 Jul 28;10:1219744. doi: 10.3389/fcvm.2023.1219744. eCollection 2023.
This retrospective study evaluates the performance of UK National Institute for Health and Care Excellence (NICE) Guidelines on management of ruptured abdominal aortic aneurysms in a "real world setting" by emulating a hypothetical target trial with data from two European Aortic Centers.
Clinical data was retrospectively collected for all patients who had undergone ruptured endovascular aneurysm repair (rEVAR) and ruptured open surgical repair (rOSR). Survival analysis was performed comparing NICE compliance to usual care strategy. NICE compliers were defined as: female patients undergoing rEVAR; male patients >70 years old undergoing rEVAR; and male patients ≤70 years old undergoing rOSR. Hemodynamic instability was considered additionally.
This multicenter study included 298 patients treated for rAAA. The majority of patients were treated with rOSR (186 rOSR vs. 112 rEVAR). Overall, 184 deaths (68 [37%] with rEVAR and 116 [63%] with rOSR) were observed during the study period. Overall survival under usual care was 69.2% at 30 days, 56.5% at one year, and 42.4% at 5 years. NICE compliance gave survival outcomes of 73.1% at 30 days, 60.2% at 1 year and 42.9% at 5 years. The risk ratios at these time points, comparing NICE-compliance to usual care, were 0.88, 0.92 and 0.99, respectively.
We support NICE recommendations to manage men below the age of 71 years and hemodynamic stability with rOSR. There was a slight survival advantage for NICE compliers overall, in men >70 years and women of all ages.
本回顾性研究通过利用来自两个欧洲主动脉中心的数据模拟一项假设的目标试验,评估英国国家卫生与临床优化研究所(NICE)关于破裂腹主动脉瘤管理指南在“真实世界环境”中的表现。
回顾性收集所有接受破裂性血管内动脉瘤修复术(rEVAR)和破裂性开放手术修复术(rOSR)患者的临床数据。进行生存分析,比较符合NICE指南情况与常规护理策略。符合NICE指南者定义为:接受rEVAR的女性患者;年龄>70岁接受rEVAR的男性患者;年龄≤70岁接受rOSR的男性患者。另外还考虑了血流动力学不稳定情况。
这项多中心研究纳入了298例接受rAAA治疗的患者。大多数患者接受了rOSR(186例rOSR vs. 112例rEVAR)。总体而言,在研究期间观察到184例死亡(rEVAR组68例[37%],rOSR组116例[63%])。常规护理下的总体生存率在30天时为69.2%,1年时为56.5%,5年时为42.4%。符合NICE指南的患者生存率在30天时为73.1%,1年时为60.2%,5年时为42.9%。在这些时间点,将符合NICE指南情况与常规护理进行比较的风险比分别为0.88、0.92和0.99。
我们支持NICE关于对71岁以下男性和血流动力学稳定患者采用rOSR进行管理的建议。总体而言,在70岁以上男性和所有年龄段女性中,符合NICE指南者有轻微的生存优势。